MX2017007953A - Tratamiento de la degeneración de la retina mediante el uso de células progenitoras. - Google Patents
Tratamiento de la degeneración de la retina mediante el uso de células progenitoras.Info
- Publication number
- MX2017007953A MX2017007953A MX2017007953A MX2017007953A MX2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- progenitor cells
- treatment
- retinal degeneration
- retinal
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 4
- 201000007737 Retinal degeneration Diseases 0.000 title abstract 2
- 230000004258 retinal degeneration Effects 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 3
- 230000002207 retinal effect Effects 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003636 conditioned culture medium Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000608 photoreceptor cell Anatomy 0.000 abstract 1
- 230000001228 trophic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462092658P | 2014-12-16 | 2014-12-16 | |
| US201562236732P | 2015-10-02 | 2015-10-02 | |
| PCT/US2015/063931 WO2016099949A2 (en) | 2014-12-16 | 2015-12-04 | Treatment of retinal degeneration using progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017007953A true MX2017007953A (es) | 2018-02-09 |
Family
ID=56110114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007953A MX2017007953A (es) | 2014-12-16 | 2015-12-04 | Tratamiento de la degeneración de la retina mediante el uso de células progenitoras. |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| MX2018006729A (es) * | 2015-12-04 | 2018-11-09 | Janssen Biotech Inc | Tratamiento de la degeneracion de la retina mediante el uso de celulas progenitoras. |
| JP6799248B2 (ja) * | 2016-09-28 | 2020-12-16 | 澁谷工業株式会社 | 細胞シートの切断方法 |
| WO2018102174A1 (en) * | 2016-12-01 | 2018-06-07 | Janssen Biotech, Inc. | Treatment of retinal degeneration using progenitor cells |
| GB201703058D0 (en) | 2017-02-24 | 2017-04-12 | Ucl Business Plc | Biomarkers |
| KR102091567B1 (ko) * | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
| CN109456937A (zh) * | 2018-12-27 | 2019-03-12 | 广州赛莱拉干细胞科技股份有限公司 | 一种制备子宫内膜干细胞的培养基以及制备方法 |
| US10758571B1 (en) | 2019-04-09 | 2020-09-01 | Combangio, Inc. | Processes for making and using a mesenchymal stem cell derived secretome |
| WO2021207282A2 (en) | 2020-04-07 | 2021-10-14 | Combangio, Inc. | Lyophilized mesenchymal stem cell derived secretome and uses thereof |
| CN115998845B (zh) * | 2020-10-26 | 2026-04-10 | 上海交通大学医学院附属第九人民医院 | 血小板反应蛋白1在制备预防和/或治疗视网膜损伤的药物中的应用 |
| CN115177717B (zh) * | 2022-08-31 | 2026-02-06 | 贵州医科大学附属医院 | 一种治疗眼表及角膜上皮疾病的药物 |
| CN117004554B (zh) * | 2023-08-09 | 2026-01-06 | 北京燕麝生物科技发展有限公司 | 一种林麝香腺细胞的培养基及林麝香腺细胞的培养方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) * | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| ES2569780T3 (es) * | 2003-06-27 | 2016-05-12 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas |
| US9572840B2 (en) * | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
| US20130251670A1 (en) * | 2011-09-13 | 2013-09-26 | Aidan Products, Inc | Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof |
-
2015
- 2015-12-04 RU RU2017124983A patent/RU2017124983A/ru not_active Application Discontinuation
- 2015-12-04 EP EP15870680.4A patent/EP3233096A4/en not_active Withdrawn
- 2015-12-04 KR KR1020177019177A patent/KR20170094368A/ko not_active Withdrawn
- 2015-12-04 SG SG11201704668PA patent/SG11201704668PA/en unknown
- 2015-12-04 WO PCT/US2015/063931 patent/WO2016099949A2/en not_active Ceased
- 2015-12-04 AU AU2015363088A patent/AU2015363088A1/en not_active Abandoned
- 2015-12-04 CA CA2970641A patent/CA2970641A1/en not_active Abandoned
- 2015-12-04 MX MX2017007953A patent/MX2017007953A/es unknown
- 2015-12-04 US US14/960,006 patent/US20160166619A1/en not_active Abandoned
- 2015-12-04 BR BR112017012581A patent/BR112017012581A2/pt not_active Application Discontinuation
- 2015-12-04 JP JP2017532063A patent/JP2018500325A/ja active Pending
- 2015-12-04 CN CN201580076297.2A patent/CN107249608A/zh active Pending
- 2015-12-16 TW TW104142367A patent/TW201632620A/zh unknown
-
2017
- 2017-06-02 PH PH12017501028A patent/PH12017501028A1/en unknown
- 2017-07-14 ZA ZA2017/04793A patent/ZA201704793B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017012581A2 (pt) | 2017-12-26 |
| CN107249608A (zh) | 2017-10-13 |
| PH12017501028A1 (en) | 2018-03-05 |
| US20160166619A1 (en) | 2016-06-16 |
| WO2016099949A2 (en) | 2016-06-23 |
| ZA201704793B (en) | 2019-01-30 |
| TW201632620A (zh) | 2016-09-16 |
| RU2017124983A3 (cg-RX-API-DMAC10.html) | 2019-06-05 |
| JP2018500325A (ja) | 2018-01-11 |
| EP3233096A2 (en) | 2017-10-25 |
| KR20170094368A (ko) | 2017-08-17 |
| SG11201704668PA (en) | 2017-07-28 |
| EP3233096A4 (en) | 2018-08-22 |
| CA2970641A1 (en) | 2016-06-23 |
| AU2015363088A1 (en) | 2017-06-15 |
| RU2017124983A (ru) | 2019-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501028A1 (en) | Treatment of retinal degeneration using progenitor cells | |
| MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
| AU2019268074A1 (en) | Methods for treating hepcidin-mediated disorders | |
| GB2541571A (en) | Pharmaceutical compositions | |
| MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
| GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| PH12016501809A1 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
| MX2018006398A (es) | Composiciones que comprenden cepas bacterianas. | |
| EP3800248A3 (en) | Crispr-cas-related methods, compositions and components for cancer immunotherapy | |
| EP3556858A3 (en) | Crispr/cas-related methods and compositions for treating cystic fibrosis | |
| MX2021009309A (es) | Modulacion de la actividad del complemento. | |
| MX369623B (es) | Compuestos biciclicos fusionados para el tratamiento de enfermedades. | |
| MX2018000715A (es) | Metodos para tratar cancer usando apilimod. | |
| EP3189036A4 (en) | Compositions and methods for treating proliferation disorders | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
| IL251616B (en) | Methods and compounds for the treatment and prevention of muscle mass loss | |
| MX2017010883A (es) | Composicion para el tratamiento de la infertilidad. | |
| PH12017500602A1 (en) | Methods for treating ocular conditions | |
| MX2019006552A (es) | Terapia génica para mucopolisacaridosis de tipo i. | |
| WO2019087130A3 (en) | Method of inhibiting angiogenesis | |
| PH12017501864A1 (en) | Compositions and methods for treating autism | |
| PH12017501022B1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| MX2016009056A (es) | Composiciones y metodos para tratamiento de crecimiento celular anormal. | |
| MX382092B (es) | Compuestos heterocíclicos para el tratamiento de enfermedades. |